Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort study
N Nielsen(Aalborg University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), Trine Trab(University of Copenhagen), Daniel Tuyet Kristensen(Aalborg University Hospital), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Jonas Jensen(Aalborg University Hospital), Andreas Due Ørskov(Zealand University Hospital), Claudia Schöllkopf, Lene Sofie Granfeldt(Odense University Hospital), Hans Beier Ommen(Centre de Recherche Jean Pierre Aubert), Joachim Bæch(Aalborg University Hospital)
Cited by 0
Related Papers
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML
|Blood|2024|78
Postinduction molecular MRD identifies patients with <i>NPM1</i> AML who benefit from allogeneic transplant in first remission
|Blood|2024|75